Erwin G. Van Meir

89.7k total citations · 4 hit papers
171 papers, 16.2k citations indexed

About

Erwin G. Van Meir is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Erwin G. Van Meir has authored 171 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Molecular Biology, 59 papers in Cancer Research and 56 papers in Oncology. Recurrent topics in Erwin G. Van Meir's work include Glioma Diagnosis and Treatment (40 papers), Cancer, Hypoxia, and Metabolism (39 papers) and Cancer-related Molecular Pathways (26 papers). Erwin G. Van Meir is often cited by papers focused on Glioma Diagnosis and Treatment (40 papers), Cancer, Hypoxia, and Metabolism (39 papers) and Cancer-related Molecular Pathways (26 papers). Erwin G. Van Meir collaborates with scholars based in United States, Switzerland and Japan. Erwin G. Van Meir's co-authors include Daniel J. Brat, Nicolas de Tribolet, Balveen Kaur, Anita C. Bellail, Jeffrey J. Olson, Costas G. Hadjipanayis, Dawn E. Post, Annie‐Claire Diserens, Satoru Osuka and Marie‐France Hamou and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Erwin G. Van Meir

170 papers receiving 15.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma

2010 1.1k citations Erwin G. Van Meir, Costas G. Hadjipanayis et al. profile →
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5

2001 686 citations Erwin G. Van Meir et al. profile →
The role of interleukin-8 and its receptors in gliomagenesis and tumoralangiogenesis

2005 610 citations Daniel J. Brat, Erwin G. Van Meir et al. Neuro-Oncology profile →
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth andangiogenesis

2005 540 citations Balveen Kaur, Fatima W. Khwaja et al. Neuro-Oncology profile →

Peers

Countries citing papers authored by Erwin G. Van Meir

Since Specialization

Citations

This map shows the geographic impact of Erwin G. Van Meir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin G. Van Meir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin G. Van Meir more than expected).

Fields of papers citing papers by Erwin G. Van Meir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin G. Van Meir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin G. Van Meir. The network helps show where Erwin G. Van Meir may publish in the future.

Co-authorship network of co-authors of Erwin G. Van Meir

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin G. Van Meir. A scholar is included among the top collaborators of Erwin G. Van Meir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin G. Van Meir. Erwin G. Van Meir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The emerging role of metabolic interventions in uveal melanoma 2025 ·Seminars in Cancer Biology ·Yuki Kuranaga, (unknown), Hans E. Grossniklaus, Sameh S. Ali, Erwin G. Van Meir	1
2	Generation and initial characterization of mice lacking full‐length BAI3 (ADGRB3) expression 2023 ·Basic & Clinical Pharmacology & Toxicology ·(unknown), Jennifer C. Wong, Debanjan Bhattacharya, Yuki Kuranaga, (unknown), (unknown), Sushant Bhatnagar, Erwin G. Van Meir, Andrew Escayg	3
3	N-cadherin upregulation mediates adaptive radioresistance in glioblastoma 2021 ·Journal of Clinical Investigation ·Satoru Osuka, Dan Zhu, Zhaobin Zhang, (unknown), (unknown), Oltea Sampetrean, Jeffrey J. Olson, G. Yancey Gillespie, Hideyuki Saya, Christopher D. Willey, Erwin G. Van Meir	63
4	A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis 2020 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), Bing Yu, Zhaobin Zhang, Satoru Osuka, Abdessamad Zerrouqi, Milota Kaluzová, Costas G. Hadjipanayis, Richard D. Cummings, Jeffrey J. Olson, Narra S. Devi, Erwin G. Van Meir	8
5	Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma 2018 ·Clinical Cancer Research ·Monika A. Davare, (unknown), Anupriya Agarwal, Jacob P. Wagner, (unknown), Nameeta Shah, Randy Woltjer, Romel Somwar, Stephen W. Gilheeney, (unknown), Tom Mikkelson, Erwin G. Van Meir, Marc Ladanyi, Brian Druker	37
6	Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma 2018 ·Clinical Cancer Research ·Lei Dong, Shuo You, Qing Zhang, Satoru Osuka, Narra S. Devi, Štefan Kaluz, (unknown), Hua Yang, Guoliang Chen, Binghe Wang, Hans E. Grossniklaus, Erwin G. Van Meir	52
7	Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase 2016 ·Clinical Cancer Research ·Juliya Kalinina, Jun Young Ahn, Narra S. Devi, (unknown), Yuancheng Li, Jeffrey J. Olson, Michael Glantz, Thomas W. Smith, Ella L. Kim, Alf Giese, Randy L. Jensen, Clark C. Chen, Bob S. Carter, Hui Mao, Miao He, Erwin G. Van Meir	52
8	Efficacy of A Novel Anti-tumor Agent KCN1 in the Control of Ocular Melanoma In vitro and In vivo 2013 ·Investigative Ophthalmology & Visual Science ·Qing Zhang, Hua Yang, Štefan Kaluz, Erwin G. Van Meir, Hans E. Grossniklaus	1
9	Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP 2012 ·Clinical Cancer Research ·Shaoman Yin, Štefan Kaluz, Narra S. Devi, Adnan Abdul Jabbar, Rita G. de Noronha, Ji-Young Mun, Zhaobin Zhang, (unknown), Wei Wang, Zhibo Wang, Thomas J. Abbruscato, Zhengjia Chen, Jeffrey J. Olson, Ruiwen Zhang, Mark M. Goodman, (unknown), Erwin G. Van Meir	71
10	P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3 2012 ·Journal of Clinical Investigation ·Abdessamad Zerrouqi, Beata Pyrzyńska, Maria Febbraio, Daniel J. Brat, Erwin G. Van Meir	52
11	Overexpression of MBD2 in Glioblastoma Maintains Epigenetic Silencing and Inhibits the Antiangiogenic Function of the Tumor Suppressor Gene BAI1 2011 ·Cancer Research ·Dan Zhu, Stephen Hunter, Paula M. Vertino, Erwin G. Van Meir	62
12	Proteomics of gliomas: Initial biomarker discovery and evolution of technology 2011 ·Neuro-Oncology ·Juliya Kalinina, Peng Jin, James Ritchie, Erwin G. Van Meir	73
13	Natural Mutagenesis of Human Genomes by Endogenous Retrotransposons 2010 ·Cell ·Rebecca C. Iskow, Michael T. McCabe, Ryan E. Mills, (unknown), W. Stephen Pittard, Andrew F. Neuwald, Erwin G. Van Meir, Paula M. Vertino, Scott E. Devine	418
14	Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity 2009 ·Cancer Research ·Yuan Rong, Vladimir E. Belozerov, Carol Tucker‐Burden, (unknown), Donald L. Durden, Jeffrey J. Olson, Erwin G. Van Meir, Nigel Mackman, Daniel J. Brat	114
15	Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism 2009 ·Cancer Research ·Balveen Kaur, (unknown), Eric M. Sandberg, Narra S. Devi, Zhaobin Zhang, Philip A. Klenotic, Maria Febbraio, Hyunsuk Shim, Hui Mao, Carol Tucker‐Burden, Roy L. Silverstein, Daniel J. Brat, Jeffrey J. Olson, Erwin G. Van Meir	98
16	Identification of a Novel Small Molecule HIF-1α Translation Inhibitor 2009 ·Clinical Cancer Research ·Takuhito Narita, Shaoman Yin, Christine F. Gelin, Carlos S. Moreno, Manuel Yepes, K. C. Nicolaou, Erwin G. Van Meir	99
17	Targeted Cancer Gene Therapy Using a Hypoxia Inducible Factor–Dependent Oncolytic Adenovirus Armed with Interleukin-4 2007 ·Cancer Research ·Dawn E. Post, Eric M. Sandberg, Michele Kyle, Narra S. Devi, Daniel J. Brat, Zhiheng Xu, Mourad Tighiouart, Erwin G. Van Meir	90
18	Attractin Is Elevated in the Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates Glioma Cell Migration 2006 ·Clinical Cancer Research ·Fatima W. Khwaja, Jonathan S. Duke‐Cohan, Daniel J. Brat, Erwin G. Van Meir	31
19	Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses 1998 ·International Journal of Cancer ·Michael Weller, Johannes Rieger, Cornelia Grimmel, Erwin G. Van Meir, Nicolas de Tribolet, Stanisław Krajewski, John C. Reed, Andreas von Deimling, J. Dichgans	152
20	Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses 1998 ·International Journal of Cancer ·Michael Weller, Johannes Rieger, Cornelia Grimmel, Erwin G. Van Meir, Nicolas de Tribolet, Stanisław Krajewski, John C. Reed, Andreas von Deimling, J. Dichgans	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact